The Evaluation of Tau Deposition with [<sup>18</sup>F]PI-2620 by Using a Semiquantitative Method in Cognitively Normal Subjects and Patients with Mild Cognitive Impairment and Alzheimer’s Disease

<div>Fusion images between [<sup>18</sup>F]PI-2620 PET and T1-weighted MRI in an AD patient. Intense tau deposition was observed in the bilateral temporal and occipital regions.</div>

Molecular Imaging

fig4

Figure 4

Figure 4: The Evaluation of Tau Deposition with [<sup>18</sup>F]PI-2620 by Using a Semiquantitative Method in Cognitively Normal Subjects and Patients with Mild Cognitive Impairment and Alzheimer’s Disease 

Figure 4 | The Evaluation of Tau Deposition with [18F]PI-2620 by Using a Semiquantitative Method in Cognitively Normal Subjects and Patients with Mild Cognitive Impairment and Alzheimer’s Disease 